Comprehensive Clinical Update on Chronic Myeloid Leukemia (CML): Pathophysiology, Diagnosis, Risk Stratification, and Evidence-Based Management
Prepared for the practicing hematologist/oncologist — incorporating 2023–2024 guidelines (NCCN, ELN, ESMO) and key recent trials (Eneomab, IRIS-15, OPTIC, ASCEND, […]
